Frontline BioVentures Overview

  • Investor Type
  • Venture Capital
  • Status
  • Inactive
  • Investments
  • 10
  • Portfolio
  • 5
  • Exits
  • 4
Exits

Frontline BioVentures General Information

Description

Founded in 2012, Frontline BioVentures was a venture capital firm based in Shanghai, China. The firm used to invest in the innovative life science companies with a focus on those strategic life science and technology areas that are promoted by the Chinese government for growth and development. In May 2017, the firm merged with WuXi Healthcare Ventures to form a new firm called 6 Dimensions Capital.

Contact Information

Year Founded
2012
Investor Status
Acquired/Merged
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • Building Number 33, Runhe Int'l Office Garden Lane
  • 1000 Zhangheng Road
  • Shanghai, Pudong New District 201203
  • China
+86 021 0000 0000

Frontline BioVentures Investments (10)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
GKHT Medical Technology 21-Jun-2016 Early Stage VC Logistics Generating Revenue
000 00000000 22-Apr-2016 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 00000000 0000 00.0
0000 000000 07-Dec-2015 00000 00000 Holding Companies Generating Revenue 00000000 0000 00.0
00000000 000000000 22-Jan-2015 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable
0000000000 12-Jan-2015 00000 00000 000.00 Biotechnology Profitable
000 00000000 08-Jan-2015 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 00000000 0000 00.0
0000000 0000000 00 11-Dec-2014 0000000000 00000 Diagnostic Equipment Generating Revenue
000 0000 16-Oct-2014 00000 00000 0000 Surgical Devices Generating Revenue
BIOKANGTAI 09-May-2014 Later Stage VC 000.00 Biotechnology Profitable
JC Medical Early Stage VC Other Devices and Supplies Pre-Clinical Trials
To view Frontline BioVentures’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Frontline BioVentures Exits (4)

Company Name Exit Date Exit Type Exit Size
Mid Labs 15-Jan-2019 Merger/Acquisition
00000000 000000000 31-Oct-2018 000 00000
Hua Medicine 14-Sep-2018 IPO 00000
BIOKANGTAI 07-Feb-2017 IPO 0000
To view Frontline BioVentures’s complete exits history, request access »

Frontline BioVentures Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial